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Abstract
Osteosarcomas (OS) are complex bone tumors with various genomic alterations. These alterations affect the expression and
function of several genes due to drastic changes in the underlying gene regulatory network. However, we know little about
critical gene regulators and their functional consequences on the pathogenesis of OS. Therefore, we aimed to determine
microRNA and transcription factor (TF) co-regulatory networks in OS cell proliferation. Cell proliferation is an essential part in
the pathogenesis of OS and deeper understanding of its regulation might help to identify potential therapeutic targets.
Based on expression data of OS cell lines divided according to their proliferative activity, we obtained 12 proliferation-
related microRNAs and corresponding target genes. Therewith, microRNA and TF co-regulatory networks were generated
and analyzed regarding their structure and functional influence. We identified key co-regulators comprising the microRNAs
miR-9-5p, miR-138, and miR-214 and the TFs SP1 and MYC in the derived networks. These regulators are implicated in NFKB-
and RB1-signaling and focal adhesion processes based on their common or interacting target genes (e.g., CDK6, CTNNB1,
E2F4, HES1, ITGA6, NFKB1, NOTCH1, and SIN3A). Thus, we proposed a model of OS cell proliferation which is primarily co-
regulated through the interactions of the mentioned microRNA and TF combinations. This study illustrates the benefit of
systems biological approaches in the analysis of complex diseases. We integrated experimental data with publicly available
information to unravel the coordinated (post)-transcriptional control of microRNAs and TFs to identify potential therapeutic
targets in OS. The resulting microRNA and TF co-regulatory networks are publicly available for further exploration to
generate or evaluate own hypotheses of the pathogenesis of OS (http://www.complex-systems.uni-muenster.de/
co_networks.html).
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Introduction
Osteosarcoma (OS) is a rare type of cancer frequently occurring
in children and young adolescents [1]. It is a complex tumor
typically accompanied by severe genomic instability and extensive
mutations hampering the identification of a genetic root [2–4].
These genomic alterations affect several genes to a varying extent
depending on patient and OS subtype. For instance, frequent
mutations and deletions of the tumor suppressor genes TP53, RB1,
and CDKN2A and mutations and amplification of the MYC locus
[5,6]. However, their interactions in the molecular pathogenesis and
the underlying cellular network of OS are poorly characterized.
Recently, attention has been focused on the impact of
microRNAs in OS. Besides transcription factors (TFs) that
transcriptionally regulate gene expression, microRNAs are a class
of small, conserved, non-coding RNA molecules generally acting
on the post-transcriptional level. They are mono- or polycistro-
nically transcribed, processed to mature molecules and subse-
quently incorporated into the RNA Induced Silencing Complex
(RISC). Once integrated in RISC, microRNAs are able to select
their target genes via binding to partially complementary
sequences in the 39-UTRs of mRNAs that lead to mRNA
degradation or translational inhibition. Computational prediction
methods revealed that individual microRNAs regulate hundreds of
target genes and one target gene might be regulated by several
microRNAs [7]. According to Friedman et al. [8] around 60% of
human genes are predicted to be regulated by multiple micro-
RNAs in a cooperative manner. This huge number of target genes
suggests a widespread control of biological processes including
differentiation, proliferation, migration, and apoptosis [9].
In cancer, microRNAs might serve as onco- and/or tumor
suppressor-microRNAs. Amplification or over-expression of on-
cogenic microRNAs can down-regulate tumor suppressor proteins.
Likewise, deletion or under-expression of tumor suppressor
microRNAs might lead to the up-regulation of oncogenes [10].
In addition, more than 50% of microRNA genes are located
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within fragile sites in the genome and are frequently subjected to
chromosomal alterations [11]. In this manner, they can affect
cancer development and progression.
MicroRNAs share several regulatory concepts with TFs, e.g.
they simultaneously regulate many target genes and cooperate
with other regulators. However, TFs activate or repress their
target gene expression whereas microRNAs regulate their targets
primarily through repression to fine-tune cell-specific gene
regulatory programs [12]. Because the expression of microRNAs
often depends on TF regulation and vice versa, it is not surprising
that both families of regulators are tightly related to each other in
gene regulatory networks. The coordinated transcriptional regu-
lation of microRNAs and their target genes by TFs is a recurrent
network motif. The two types of gene regulators frequently form 3-
node feedforward loops (FFLs) with common target genes [13].
Recently, Sun et al. [14] extended this regulatory motif to 4-node
FFLs by integrating additional TF target genes. The extension of
3-node to 4-node motifs illustrated a more detailed model of the
oncogenesis of glioblastoma by recruiting additional disease genes
not directly targeted by microRNAs.
Several studies have shown an involvement of microRNAs in
the pathogenesis of OS. They demonstrated down-regulation of
miR-143 in OS progression [15], up-regulation of the oncogenic
miR-17,92 cluster in OS cells [16], and regulatory functions for
miR-199a-3p [17], miR-21 [18], and miR-125b [19] in OS cell
proliferation and migration. Additional genome-wide microRNA
analyses suggested sets of microRNAs to discriminate OS from
osteoblasts and bone tissue [20–23]. All studies proposed the use of
microRNAs as biomarkers in OS that might correlate with clinico-
pathological parameters. However, those studies lack a compre-
hensive analysis of the functional consequences of aberrant
microRNA expression in OS. Analyzing microRNAs in the
context of their microRNA and TF co-regulatory networks might
provide a deeper understanding of the pathogenesis of OS.
In this study, we joined different data sources to analyze the
contribution of microRNA and TF co-regulatory 3-node and 4-
node motifs to the proliferative activity of OS cells. First, we
divided seven OS cell lines into high and low proliferation groups
by performing proliferation assays. Expression analysis based on
these groups yielded differentially expressed (DE) microRNAs and
mRNAs. Second, high efficacy microRNA target genes were
obtained by integrating computational predicted targets with DE
mRNAs. Only microRNAs with significantly enriched target genes
were considered in the analysis. Third, microRNA target genes
were clustered according to their functional similarity to explore
their distinct biological processes. Fourth, transcription factor
binding site (TFBS) information was added to assemble 3-node
and 4-node motifs of non-random microRNA and TF co-regulator
pairs. Fifth, the resulting 3-node and 4-node motifs were merged
to form microRNA and TF co-regulatory networks to examine the
coordinated regulation of microRNAs and TFs (Figure 1).
Here, we present the first study analyzing microRNA and TF
co-regulation in OS and uncover critical microRNA players of the
functional processes implicated in OS cell proliferation.
Figure 1. Workflow. The figure illustrates the procedure of the
present study determining microRNA and TF co-regulation in OS cell
proliferation.
doi:10.1371/journal.pcbi.1003210.g001
Author Summary
Osteosarcomas (OS) are bone tumors most frequently
affecting children and young adolescents. We do not know
much about its molecular pathogenesis hampering per-
sonalized therapies to more effectively cure patients. To
this day, almost all patients receive adjuvant chemother-
apies independent of its necessity. Hence, we need to gain
a comprehensive understanding of the molecular patho-
genesis of OS to uncover molecular components that can
be used as therapeutic targets. MicroRNAs and transcrip-
tion factors (TFs) are master regulators of the cellular
system. They control the amount of genes expressed in a
cell at a specific time point that ultimately results in a
distinct cellular phenotype. Here, we investigated micro-
RNA and TF co-regulatory networks in OS cell growth as
one hallmark in cancer. We uncovered key microRNA and
TF regulators that cooperatively control growth-related
pathways in OS and proposed potential therapeutic
targets. This study illustrates the benefit of analyzing
complex diseases from a network perspective because no
molecular component functions isolated from the under-
lying cellular system.
MicroRNA and TF Co-regulation in Osteosarcoma
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Results
OS cell proliferation and differential microRNA expression
In order to investigate the deregulated microRNA and TF co-
regulatory networks of proliferative OS cells, we used seven
authenticated OS cell lines. The cell lines were divided according
to their proliferative activity by performing a proliferation assay.
Four OS cell lines exhibited a high proliferative activity with a
doubling time ,10 hours while three showed less proliferation
(Table 1). MNNG/HOS, U2-OS, and SJSA-1 showed additional
extensive migratory capabilities. The expression analysis of the
microRNAs was based on these two proliferation groups. The
analysis yielded nine down-regulated and eight up-regulated
microRNAs that passed the differential expression criteria (False
discovery rate (FDR) ,0.05 & log2 Fold change (FC)$|1|,
Table 2). The derived DE microRNAs have been reported in
association with neoplastic disease either due to oncogenic or
tumor suppressor properties. Hierarchical clustering of them
clearly separated the OS cell samples according to their
proliferative activity (Figure 2). Hence, we selected the DE
microRNAs as candidates that might affect OS cell proliferation
for further analysis.
OS proliferation-related microRNA target genes
To explore the functional consequences of DE microRNAs on
OS cell proliferation, we determined their target genes by
integrating gene expression profiles with computational predicted
target genes.
First, the expression analysis of mRNAs resulted in a total of 666
up-regulated and 610 down-regulated mRNAs. We applied loose
filter criteria for DE mRNAs without correcting for multiple tests
(p-value,0.05 & log2 FC$|0.7|) because microRNA regulation
might lead to subtle changes in gene expression. Next, we
superimposed the DE genes with predicted microRNA targets to
obtain target genes affecting OS cell proliferation. We assumed
that microRNAs exhibit an inverse regulatory relationship to their
functional target genes, i.e. microRNA expression is inversely
correlated to its target gene expression. Hence, down-regulated
targets were assigned to up-regulated microRNAs in high
proliferative OS cells and vice versa.
To exclude DE microRNAs with random association to OS cell
proliferation, we tested for microRNA target gene enrichment
within the list of DE genes. Among the 17 DE microRNAs, 12 are
significantly enriched due to their targets (FDR,0.05, Table S1).
To account for different numbers of targets that might influence
the enrichment analysis, we also computed the target gene
enrichment of 1,000 permuted samples. The permutation
procedure confirmed previous results (Figure S1). Consequently,
Figure 2. Clustering of differentially expressed microRNAs. The
heatmap illustrates the expression profiles of DE microRNAs (log2
FC$|1| & FDR,0.05, y-axis) among all OS cell samples (x-axis). High
(dark blue) and low (light blue) proliferative OS samples are clearly
separated. The red/green color code corresponds to the expression
deviation from the average expression among all samples. Complete-
linkage clustering was performed with the Pearson correlation as
distance metric.
doi:10.1371/journal.pcbi.1003210.g002
Table 1. Proliferation and migration potential of OS cell lines.
Cell line Proliferation Migration
HOS-58 low low
SaOS-2 low low
ZK-58 low low
MG-63 high low
MNNG/HOS high high
SJSA-1 high high
U2-OS high high
doi:10.1371/journal.pcbi.1003210.t001
Table 2. Differentially expressed microRNAs dependent on
OS cell proliferation.
microRNA log2 FC FDR References
miR-181a 22.28 0.000013 [20]
miR-9-3p 22.01 0.00443 [23]
miR-181d 21.82 0.000028 [23]
miR-138 21.81 0.03828 [33]
miR-214 21.59 0.03083 [20]
miR-9-5p 21.44 0.00525 [23]
miR-181b 21.17 0.000028 [20]
let-7f 21.09 0.00211 [73]
miR-92b 21.06 0.000149 [74]
miR-130a 2.77 0.00698 [75]
miR-21-5p 2.31 0.03760 [18]
miR-155 2.05 0.00382 [76]
miR-222 1.87 0.00698 [77]
miR-221 1.45 0.00823 [77]
miR-100 1.26 0.03827 [22]
miR-21-3p 1.23 0.03760 [23]
miR-151-5p 1.00 0.00698 [78]
DE microRNAs are shown with their corresponding log2 FC and FDR. A negative
log2 FC indicates that microRNAs are down-regulated in high proliferative OS
cells and vice versa. The references demonstrate an implication in cancer of the
respective microRNA.
doi:10.1371/journal.pcbi.1003210.t002
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we excluded 5 microRNAs from further analyses (miR-92b, let-7f,
miR-9-3p, miR-151-5p, and miR-100). The remaining 12 OS
proliferation-related microRNAs are implicated in the regulation
of 474 target genes. Hierarchical clustering of the target genes
resulted in a distinct separation of the high and low proliferative
OS cell samples (Figure 3A).
Functional clustering of microRNA targets
We further investigated the underlying biological processes
of OS proliferation-related microRNAs. We classified micro-
RNA target genes according to their functional similarities of
their gene ontology (GO) biological process terms using fuzzy
c-means clustering (FCM). After determining FCM parame-
ters (Figure S2), we obtained two clusters. Principal Compo-
nent Analysis (PCA) supported the results. The first two
components separate the determined clusters (Figure 3B).
Cluster C1 consists of 172 members and cluster C2 contains
212 members. The remaining 90 microRNA targets could not
be annotated with a GO biological process term and were
excluded from further analysis. The clustering suggested that
the microRNA targets can be classified into two broad
functional classes.
GO enrichment analyses revealed that members of C1 are
mainly involved in metabolic processes like protein modification,
nucleic acid metabolism, and carbohydrate metabolism, whereas
members of C2 are implicated in signal transduction pathways
leading to proliferation, differentiation, apoptosis, and migration.
Both clusters demonstrate that cancer cells adapt metabolic
processes for cell proliferation and survival [24]. A comparison
between the five most informative GO terms (FDR,0.05)
illustrating the specific biological aspects of each cluster is shown
in Figure 3C.
Figure 3. Functional implications of microRNA target genes in OS proliferation. (A) Differentially expressed microRNA target genes. The
heatmap shows the expression of DE microRNA target genes (log2 FC$|0.7| & p-value,0.05, y-axis) among all OS cell samples (x-axis). High (dark
blue) and low (light blue) proliferative OS samples are grouped into distinct clusters. The red/green color code corresponds to the expression
deviation from the average expression among all samples. Complete-linkage clustering was applied with the Pearson correlation as distance metric.
(B) Principal component analysis based on GO functional similarity. The figure draws the first (x-axis) and second (y-axis) principal components based
on the GO functional similarity of microRNA target genes. The target genes are color coded according to their cluster membership determined by
FCM. The radius of each gene represents the strength of association to its cluster. (C) Comparison of the GO enrichment analyses of the distinct
clusters. Each row corresponds to a specific biological process category. The number of genes included in each category is indicated in the round
brackets. Circle sizes correspond to the percentage of row-genes located in a cluster. Significantly enriched categories are color coded in red and
random categories in blue.
doi:10.1371/journal.pcbi.1003210.g003
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Identifying microRNA and TF co-regulated target genes
Transcriptional regulation of TFs is tightly coupled with the
post-transcriptional regulation of microRNAs. We utilized their 3-
node and 4-node co-regulatory motifs to study DE microRNA and
TF co-regulation in OS cell proliferation for each functional
cluster.
Every possible 3-node and 4-node FFL motif was determined to
assess significant microRNA and TF combinations (FDR,0.2) by
using the hypergeometric test (Table S2 and S3). For the 3-node
FFL, we obtained non-random microRNA and TF pairs with
common target genes (Figure 4A). For 4-node FFL motifs, we
assessed non-random microRNA and TF pairs that regulate gene
neighbors in the protein interaction network (Figure 4B). The
individual 3-node and 4-node FFL motifs are listed in Table S4
and S5, respectively.
Subsequently, we analyzed the co-regulated target genes of
significant microRNA and TF combinations. The results are
summarized in Table 3. Noticeably, the microRNA and TF duo
with the highest number of co-regulated target genes in both
functional clusters is miR-9-5p and SP1 (Figure 5) indicating a
prominent role in OS cell proliferation.
Further, we examined the co-expression of genes co-regulated
by the same microRNA and TF pairs. We computed the Pearson
correlation coefficients between co-regulated gene pairs as a
measure of their co-expression. The distribution of the resulting
correlation values was compared to the correlation distribution of
random genes by the Kolmogorov-Smirnov (KS) test. The co-
expression of co-regulated gene pairs tends to be significantly
higher than for random genes (p-value,2.2610216, Figure 4C).
This result supports the hypothesis of non-random microRNA and
TF co-regulation within the list of their common or interacting
target genes and suggests a similar functional context for their
targets.
Generating microRNA and TF co-regulatory networks
Subsequently, we constructed the microRNA and TF co-
regulatory networks that highlighted the combinatorial regulation
patterns and regulated biological processes of microRNAs and
TFs. The networks of C1 and C2 were generated by joining all
significant co-regulatory relationships of microRNAs and TFs
(Table 3). The resultant microRNA and TF co-regulatory
networks are provided for full exploration on our website
(http://www.complex-systems.uni-muenster.de/co_networks.
html).
To assess the contribution of individual nodes in the co-
regulatory networks on the networks’ stability and robustness, we
calculated the node degree and betweenness centrality parameters.
The node degree distributions are highly right skewed. A large
fraction of nodes shows a low degree and only few nodes have high
degrees (Figure S3). Almost all microRNAs and TFs are located at
higher node degrees as indicated by their average node degrees
(C1: microRNAs 19 and TFs 19, C2: microRNAs 25 and TFs 49).
Figure 4. MicroRNA and TF co-regulatory motifs. Schematic illustration of (A) 3-node and (B) 4-node FFL motifs. A 3-node motif contains a
microRNA, a TF, and a commonly regulated target gene. In contrast, 4-node FFLs comprise a microRNA, a TF, a microRNA target gene (primary target),
and a TF target gene (secondary target) that interacts with the primary target. MicroRNAs are indicated with diamonds, TF with triangles, primary
targets with rectangles, and secondary targets with circles. (C) Coexpression of microRNA and TF target genes. The plot shows the observed and
random cumulative distribution functions (CDFs, y-axis) of the Pearson correlation coefficients (x-axis) between any gene pair regulated by a specific
microRNA and TF 3-node and 4-node motif. The observed and random CDFs are compared using the KS test. The p-values are indicated within the
plots. Green and orange color codes correspond to the distinct clusters C1 and C2.
doi:10.1371/journal.pcbi.1003210.g004
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We expected that finding as microRNA and TF co-regulation is
the main subject of the present study.
Each network contains three types of nodes, namely micro-
RNAs, TFs, and target genes. We ranked the nodes according to
their node degrees and node type. The top 25% of microRNAs
and TFs and the top 5% of target genes were considered as hubs in
the C1 and C2 networks (Table S6). We detected the hub
microRNA miR-214 and the hub TFs CREB1, SP1, and ZIC2 in
both networks suggesting a central function in OS cell prolifer-
ation. Strikingly, around 50% of microRNA and TF target gene
hubs in the two networks are TFs themselves. The microRNA and
TF co-regulatory network derived from C1 contains ATF6,
GTF2A1, HIVEP2, KLF5, LMO3, NFKB1, and TBPL1 and the
C2 network comprises BCL6, BCL6B, E2F4, HES1, JUN, LMO4,
RARA, REST, SIN3A, TCF7L2, and ZBTB16. Some of these TFs
(ATF6, E2F4, JUN, RARA, and REST) are implicated in building
3-node and 4-node FFL motifs in one or two networks. The
remaining TFs were either not existent in the UCSC conserved
TFBS track or do not produce any significant FFL. Additionally,
we found epigenetic modulators and genes involved in protein
modification processes, like protein ubiquitination and phosphor-
ylation. As already mentioned, the microRNA targets in C2 are
associated with signal transduction for maintaining OS cell
proliferation. Among the hub genes in the network derived from
C2, 30% of target gene hubs (AMOT, ARF6, CACNA1A, CTNNB1,
GRB2, NOTCH1, PDGFRB, PIK3R1, SMAD7, and TGFBR2) are
related to signaling pathways that participate in cell proliferation,
survival, and migration.
Moreover, we assessed over-represented functional pathways
derived from the KEGG database [25]. The enriched categories
(FDR,0.05) are shown in Table S7. We detected an enrichment
of genes involved in the cell cycle and cancer related pathways in
both networks. We expected to observe these functional categories
as we analyzed the proliferative potential of OS tumor cell lines.
Further, we observed a similar functional trend between the C1
and C2 networks as for their corresponding functional clusters.
Within the co-regulatory network of C2, signaling pathways are
significantly over-represented such as the MAPK-, TGFB-, and
WNT-signaling pathways. In contrast, the network of C1
comprises a significant number of genes required for the basal
transcription machinery.
Tightly connected microRNA and TF co-regulated
subnetworks
After examining the global co-regulation patterns of micro-
RNAs and TFs in both networks, we were interested in sets of
microRNAs and TFs that co-regulate densely connected network
modules. To investigate the local structure of the OS proliferation-
related co-regulatory networks, the walktrap algorithm was
applied [26].
The algorithm obtained six modules within the metabolic
network of C1 (Figure S4) and six modules in the signaling
network of C2 (Figure S5). The size and node types within each
module are indicated in Table 4. Strikingly, miR-9-5p is located in
the largest module and is regulated through the TFs ATF2,
BACH1, CREB1, and SP1 in both networks. As mentioned before,
miR-9-5p and SP1 co-regulate the largest number of target genes
and thus indicate a prominent function in OS cell proliferation.
Further, we run the Functional Annotation clustering Tool of
the DAVID database [27] to classify the distinct network modules
according to their GO biological process and molecular function
terms. We annotated each module with the biological aspect of its
maximum enrichment score (ES). Among the 12 modules, five are
mainly involved in transcriptional regulation processes, which is in
accordance with previous studies that illustrated that microRNAs
function via TFs to regulate various biological processes like cell
proliferation [28,29]. Despite the top scored biological associa-
tions, one module (C2.1) is related to negative regulation of
differentiation (ES.3.9), particularly to osteoblast differentiation
due to the genes CDK6, MEN1, SKI, SMAD3, and SOX2, which
might provide a link to the pathogenesis of OS (Figure S5A).
Within this module, the TF MYC (node degree 83) co-regulates
several targets with miR-138 (node degree 25). The top ranked
target gene in this module is SIN3A (node degree 57).
Discussion
OS is a complex tumor with varying degrees of genomic
alterations and affected disease genes. This genomic complexity
makes it difficult to identify a genetic cause and deregulated
pathways in the pathogenesis of OS. Systems biological approach-
es provide tools to investigate the interactions between candidate
genes by integrating different data sources on the network level.
Thereof, cooperative or compensative effects between candidate
genes might be observed. Hence, network-based approaches
seemed to be ideally suited to study the implication of functional
pathways in OS. This study represents the first attempt to
investigate microRNA and TF co-regulatory networks in the
pathogenesis of OS. In the course of the study, several data sources
were integrated, namely microRNA and mRNA expression
profiles, TFBS information, and protein interaction data. There-
with, we aimed to unravel possible candidate genes and their
interplay that ultimately result in a high proliferative phenotype of
OS cell lines. The derived microRNA and TF networks are
publicly available (http://www.complex-systems.uni-muenster.de/
co_networks.html).
Table 3. Summary of proliferation-related microRNA and TF co-regulations.
Cluster Motif microRNA TF Primary targets Secondary targets microRNA and TF pairs
C1 3-node FFL 10 17 58 — 29
4-node FFL 8 20 69 227 23
total 10 29 85 213 46
C2 3-node FFL 10 31 88 — 58
4-node FFL 9 21 81 581 29
total 10 35 117 550 70
The table specifies the number of common and interacting target genes between non-random microRNA and TF pairs for 3-node and 4-node motifs and for the total
co-regulatory network they form.
doi:10.1371/journal.pcbi.1003210.t003
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OS proliferation-related microRNAs are associated with a
proliferative phenotype
The microRNA and TF co-regulatory networks modeling OS
cell proliferation are based on 12 proliferation-related micro-
RNAs. Among these microRNAs, 11 were previously mentioned
in OS [20,22,23,18], whereas miR-138 was exclusively obtained in
this study. Previous studies focused on global microRNA
alterations in OS with respect to osteoblast cells and bone tissue.
However, microRNA expression was partially inconsistent be-
tween different studies. Namløs et al. [23] hypothesized that
contradictory microRNA regulation in different genome-wide
studies might be explained due to distinct differentiation stages of
Figure 5. miR-9-5p and SP1 co-regulatory motifs. The co-regulatory motifs of miR-9-5p and SP1 are illustrated as graphs with nodes and edges
for (A) C1 and (B) C2. MicroRNAs are marked with diamonds, TFs with triangles, primary targets with rectangle, and secondary targets with a circle.
Yellow edges tag protein-DNA interactions, blue edges microRNA-target interactions, and dashed edges protein interactions. The red/green color
code presents the corresponding log2 FC.
doi:10.1371/journal.pcbi.1003210.g005
MicroRNA and TF Co-regulation in Osteosarcoma
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OS progenitor cells. In this study, the DE microRNAs were
assessed between high and low proliferative OS cells. The varying
proliferation activity between these cell lines might reflect distinct
differentiation stages of their progenitor cells. This might explain
the detection of proliferation-related microRNAs in global OS
studies.
In different biological contexts the down-regulated microRNAs
have been associated with decreased proliferation [30–33]. In
turn, up-regulated microRNAs have been related to an increased
proliferation potential [34–37]. These studies emphasize the
proposed influence of the derived microRNAs on OS cell
proliferation.
miR-9-5p and SP1 co-regulated targets are highly
involved in OS cell proliferation
The assembly of non-random microRNA and TF co-regulators
revealed several interesting combinations. Based on the huge
number of co-regulated target genes, the most notably co-
regulation duo is the miR-9-5p and SP1 pair. Depending on the
derived cluster, these co-regulators seem to affect distinct
functional pathways due to their target genes.
The C1 derived miR-9-5p and SP1 co-regulated target genes
seem to participate in NFKB-signaling. Commonly regulated target
genes include the TFs NFKB1, NFKB2, RELA, RELB, and BCL3
and the inhibitors NKRF, NFKBIA, and TNIP2 that cooperatively
activate or block target gene expression of NFKB, respectively [38].
This pathway is implicated in OS cell proliferation [39], and
NFKB1 is an experimentally validated target gene of miR-9-5p [40].
Furthermore, a regulatory circuit including SP1/NFKB1/HDAC
and miR-29b is known to induce leukemic growth [41]. Thus, miR-
9-5p might function in a similar context in OS than miR-29b in
leukemia.
On the other hand, the C2 derived miR-9-5p and SP1 co-
regulated genes might be involved in focal adhesion. We observed
cadherins (CDH1, CDH2, DSC2, and DSG2), further cell adhesion
molecules (e.g. FN1, ITGA6, ITGB1, JUP, PKP3, and VCL), and
calcium signaling receptors (e.g. CACNA1A and CALR). According
to StringDB [42], almost all commonly regulated genes interact
with each other indicating a functional association (Figure S6). A
possible pathway of miR-9-5p and SP1 co-regulation could
implicate CDH1 and CTNNB1 that modulate cell proliferation
[43]. CTNNB1 is not a commonly regulated target gene of miR-9-
5p and SP1. However, we observed some of its binding partners
(e.g. CDH1, CDH3, CTNNBPI1, RUNX2, and SMAD7). Addition-
ally, CTNNB1 is a hub gene in the C2 co-regulatory network.
Moreover, increased expression of miR-9-5p resulted in down-
regulation of the NFKB-SNAIL pathway and simultaneously to up-
regulation of CDH1 in melanoma cells [44]. All these observations
suggest a central role of miR-9-5p and SP1 co-regulation in OS cell
proliferation.
Functional implications of the miR-138-MYC-SIN3A
module in the pathogenesis of OS
Merging significant microRNA and TF co-regulators resulted in
co-regulatory networks of C1 and C2. The networks provided a
global view on microRNA and TF co-regulation in OS cell
proliferation. To analyze the local co-regulation patterns within
the networks, we specifically extracted densely connected modules.
One of these modules, namely the C2.1 module, is implicated in
negative regulation of differentiation, particularly osteoblast
differentiation. It contains the hubs miR-138, MYC, and SIN3A.
We hypothesize a function for members of C2.1 that might be
specific for the pathogenesis of OS. According to StringDB [42],
the genes in the module form a densely connected network
illustrating a tight functional relationship (Figure S7). The module
comprises members of the cell cycle (CCND1, CCND3, CDKN1A,
CDKN2C, and CDK6), all involved in the RB1-pathway [45]. The
complex of the module members SIN3A, NCOR1, SKI, and HDAC
can bind to RB1 and repress E2F target genes [46]. Therefrom, we
assumed a connection between module members and RB1, which
has been reported to be frequently deregulated in OS [5].
Further, SIN3A is an experimentally validated target gene of
miR-138 [47]. In the global co-regulatory network of C2 as well as
in C2.1 module, it depicts a hub gene. Its role in cancer is
contradictory, on the one hand it shows tumor suppressor
functions [48]. On the other hand, it acts in tumor growth [49].
Table 4. MicroRNA and TF co-regulatory subnetworks.
ID microRNA TF nodes edges associated biology p-valuea
C1.1 miR-221, -222, -130a, -
21-5p
JUN, HSF2, SRF, HSF1, FOXC1, I
RF7, FOXO1, YY1
72 156 transcription 2.0610203
C1.2 miR-21-3p E2F1, STAT3 33 53 phosphorylation 3.0610203
C1.3 miR-214 BPTF, ZEB1, E2F4, NFIL3 62 120 cell cycle 5.6610203
C1.4 miR-9-5p CREB1, CEBPB, ATF2, SP1, ZIC2, TCF3, BACH1 91 248 transcription 1.0610211
C1.5 miR-181a, -181b MEF2A, TBP, SREBF1, MAX, POU2F1 60 142 chromosome organization 8.1610204
C1.6 miR-138 MYC, KLF12 19 32 — —
C2.1 miR-138 MYC, FOXC1, USF1, ZIC1, FOXJ2 157 377 transcription 1.0610217
C2.2 miR-21-5p, -21-3p STAT3, IRF9, SOX9, MEF2A 70 124 transport 5.6610203
C2.3 miR-222, -221, -214 RORA, NR3C1, FOXO1 127 235 transcription 1.0610204
C2.4 miR-130a CEBPB, ZEB1, GATA2, SRF, YY1 87 144 differentiation 9.8610204
C2.5 miR-181a, -181b POU2F1, KLF12, NFIL3 21 41 — —
C2.6 miR-9-5p CREB1, TP53, NR2F2, NFIC, EGR1, ATF6, ATF2,
PAX6, SREBF1, SP1, BACH1, NFATC1
247 887 transcription 4.1610212
For each module the comprised microRNAs, TFs, number of nodes and edges, and associated biological aspects with corresponding p-values are presented.
aES$2.0.
— no significant associated biological aspect.
doi:10.1371/journal.pcbi.1003210.t004
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Taken together with the fact that SIN3A can interact with RB1, we
suggest a possible role for SIN3A in the pathogenesis of OS.
Model of OS cell proliferation
After examining and discussing the structural and functional
aspects of the co-regulatory networks, we integrated the main
results of the present study into a potential model of OS cell
proliferation (Figure 6). The focus of the model is on microRNA
and TF co-regulation of the microRNAs miR-9-5p, miR-138, and
miR-214 and the TFs SP1 and MYC.
In proliferative active OS cell lines, miR-9-5p, miR-138, and
miR-214 are significantly down-regulated leading to the up-
regulation of their direct target genes CDK6, E2F4, HES1,
ITGA6, NFKB1, NOTCH1, and SIN3A. CDK6 phosphorylates
RB1 and therewith the RB1/SIN3A/SKI/NCOR1/HDAC com-
plex cannot repress E2F4 target gene expression [45,46].
Activated NOTCH1 induces HES1 and sustains NFKB-signaling
through NFKB1, NFKB2, RELA, RELB [50]. CTNNB1 stabilizes
cell-cell adhesions in complex with CDH1. Unbound CTNNB1
can translocate to the nucleus [43]. All these signals end up in
the nucleus where they induce expression of proliferation
promoting genes like microRNAs up-regulated in high prolifer-
ative OS cells, CCND1, and FN1. In turn, they repress genes
implicated in growth-arrest.
Conclusion
The resulting microRNA and TF co-regulatory networks
display a detailed picture of the regulation of OS cell proliferation.
In the present study, we concentrated on distinct functional aspects
unraveled from the networks. The outcome suggests that down-
regulation of miR-9-5p, miR-138, and miR-214 results in a strong
proliferative phenotype of OS cells due to their impact on NFKB-
and RB1-signaling and on focal adhesion.
Our study provides potential therapeutic targets in OS and
proposes concepts for further research. In addition, we demon-
strated how systems biological approaches support the analyses of
complex diseases.
Materials and Methods
Data sets
We used microRNA and mRNA expression data of seven
authenticated OS cell lines, six from our previously published
study [16] and one additional (ZK-58). Prior to microarray
analyses, RNA was isolated and further processed as described in
[16]. MicroRNA and mRNA expression profiles were determined
on Exiqon’s miRCURY LNA and Affymetrix’s Human Gene 1ST
arrays, respectively.
Conserved TFBSs (hg19) were downloaded from the UCSC
Table Browser [51]. The track contained predicted TFBSs
Figure 6. Model of OS cell proliferation. The picture illustrates the proposed model of OS cell proliferation co-regulated by miR-9-5p, miR-138,
and miR-214 and the TFs SP1 and MYC. These regulators control mainly components of the NFKB- and RB1-pathway and of focal adhesion processes.
Primary microRNA targets are rectangular and secondary targets are ellipse shaped. Red marks up-regulated genes in proliferative active OS cell lines
and green indicates down-regulated genes. White nodes represent genes not DE in OS cell proliferation. Solid and dashed arrows illustrate direct and
indirect functional associations, respectively. RB1 is shaded in red to indicate that it is no member of the global networks.
doi:10.1371/journal.pcbi.1003210.g006
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conserved in the human/mouse/rat alignment that were deter-
mined by using the Transfac Matrix Database 7.0 [52]. Protein
interaction data were obtained from BioGRID release 3.1.92 [53].
Proliferation assay to group OS cell lines
The OS cell lines were evaluated regarding their proliferative,
migrative, and invasive potential by using in vitro-assays (BD
Biosciences). Cells utilized in the assays showed 60 to 80%
confluence growth. Prior to the assays cell lines were synchronized
to ensure a uniform cell growth.
To analyze OS cell proliferation, duplicates of each cell line
(16105 cells) were seeded in 25 cm2 cell culture flasks. Cells were
harvested at 24, 48, 72, 96, and 168 hours of growth. The cell
number was determined by an automated cell counter (Beckman
Coulter). For each cell line and time point, the mean cell number
was calculated to estimate the growth rate and subsequently the
doubling time.
Further, the Biocoat Matrigel Invasion Assay and a migration
assay (BD Biosciences) were performed for each cell line in
duplicate with matrigel-coated and uncoated inserts, respectively.
Experiments were performed according to the manufacturer’s
instructions. Evaluation of invaded and migrated cells was done
after 24 and 48 hours by light-microscopic analysis. Ten visual
fields (magnification 106) were analyzed by counting stained cells
on the membranes.
Expression analysis of microRNAs and mRNAs
The expression data sets were analyzed using the Bioconductor
package limma [54]. DE genes between high and low proliferative
OS cells were determined using eBayes [54].
MicroRNA expression data were annotated with miRBase
release 18 [55], background corrected by normexp+offset 10 [56],
and normalized with printtiploess followed by RQuant [57]. In the
differential expression analysis we considered the top 75% of
microRNA probes that showed largest variation over all samples.
Multiple test correction was performed using Benjamini and
Hochberg’s FDR approach [58].
The mRNA expression data were preprocessed by the
Bioconductor package affy [59]. The Affymetrix Human Gene 1
ST array contains probes mapping among the whole transcript.
Therefore, we filtered probes that mapped to exons present in at
least 80% of a gene’s transcripts to get one stable expression value
per gene. Transcripts were derived from Ensembl release 63 [60].
The raw probe intensities were background corrected, normalized,
and summarized to the gene-level by applying the robust multi-
array average algorithm (rma) [59].
MicroRNA and TF target prediction
Predicted microRNA targets were obtained by running the local
perl scripts targetscan_60.pl and targetscan_61_context_scores.pl
that were online available at the TargetScan website (http://www.
targetscan.org/) [61]. Mature microRNA sequences were down-
loaded from miRBase release 18 [55]. To derive high efficacy
targets, we filtered target predictions with a context score#20.1
[61].
To determine TF target genes, we downloaded the transcrip-
tional start sites (TSSs) of all genes included in the mRNA
expression data set from the hg19 assembly of the UCSC Table
Browser [51] and the TSSs from our proliferation related
microRNA genes from miRStart [62]. Further, we defined the
promoter region to2/+ 2000 nucleotides around the TSSs. Genes
having a TFBS that completely overlapped their promoter regions
were considered as TF targets. We just considered human TFs that
were expressed in at least one proliferation group of our OS cell
samples (log2 intensity$8).
Enrichment of microRNA target genes
To assess the enrichment of microRNA target genes in the list of
DE genes, a hypergeometric test was performed. Multiple test
correction was done by determining the FDR according to
Benjamini and Hochberg [58]. To account for the different
number of target genes of the DE microRNAs, a permutation
procedure was applied. We randomly selected the number of DE
genes out of the genes in our mRNA expression data set and
counted the number of random microRNA target genes. For each
permutation an enrichment score (ES, -log10 p-value) was
calculated. The permutation procedure was repeated 1,000 times.
The resulting permutation p-values were obtained by counting the
number of permuted ESs exceeding the observed one. This was
done for all DE microRNAs separately.
Fuzzy c-means clustering of DE microRNA targets
To classify DE microRNA targets according to their functional
similarity, their GO semantic similarity scores based on biological
process terms were computed using Resnik’s information content
approach of the GOSim package [63]. The resulting functional
similarity scores for any target gene pair were listed in a similarity
matrix, which was further utilized as distance matrix for clustering.
We applied FCM [64] to classify microRNA target genes
according to their functional similarity using the function fanny
from the R cluster package [65]. The fuzziness parameter was
estimated by Dunn’s coefficient [66] among a range of 1.1 to 1.5
and the cluster number was estimated over a range of 2 to 15 using
Dunn’s index [67]. The Dunn coefficient (range 0–1) indicates the
fuzziness of a cluster [66]. The Dunn index compared the between
cluster variation to the within cluster variation and measures the
cluster separation. A Dunn index .1 indicates a satisfying
clustering [67].
The derived functional clusters were evaluated by running a
GO enrichment analysis with the Bioconductor package GOStats
[68]. Multiple test correction was performed by using Benjamini
and Hochberg’s FDR approach [58].
Testing and evaluating microRNA and TF co-regulation
We tested for non-random microRNA and TF 3-node and 4-
node motifs by using the hypergeometric test adapted from Sun et
al. [14]. In contrast to them, we applied a different null model to
derive p-values specific for the underlying microRNA and TF co-
regulation pairs.
For the 3-node motifs we tested if a microRNA and TF pair had
significantly more commonly DE target genes than computation-
ally predicted target genes. In turn, co-regulation of microRNA
and TF pairs in 4-node motifs was tested based on commonly
regulated secondary target genes and compared to the genes with
corresponding TFBS in the whole 1st-neighbor protein interaction
network. The 1st-neighbor protein interaction network was
determined by extracting all 1st-neighbors of microRNA target
genes from the protein interaction data. Benjamini and Hoch-
berg’s FDR was used to adjust for multiple testing [58].
Furthermore, evaluation of significant pairs of microRNAs and
TFs was performed by assessing the coexpression of genes targeted
by the same microRNA and TF pair. The Pearson correlation was
used as a measure for coexpression. Statistical significance was
determined by a permutation procedure. We randomly chose the
same number of genes targeted by 3-node and 4-node FFLs out of
all genes annotated in the mRNA expression data and computed
their correlation coefficients. The permutation procedure was
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repeated 1,000 times. Finally, we tested if the coexpression of the
genes in the FFLs was significantly greater than in randomly
selected gene pairs using the KS test.
MicroRNA and TF co-regulatory network generation and
analyses
The microRNA and TF co-regulatory networks were construct-
ed by merging all 3-node and 4-node FFL motifs. The networks
were modeled as graphs with nodes and edges. Nodes corre-
sponded to microRNAs, TFs, or target genes and edges
corresponded to microRNA-target regulation, TF-target regula-
tion, or protein interactions. To identify crucial network players,
we computed network centralities, namely node degree and
betweenness, using the R package igraph [26]. The node degree is
defined as the number of direct neighbors of a node in a network.
Nodes having a high number of direct neighbors are thought to be
important regulatory hubs inside the network. In contrast, a node’s
betweenness is a measure of the number of shortest paths between
any pair of nodes that run through it [69].
To detect tightly connected groups of nodes in the network, we
run the walktrap algorithm [70]. This algorithm finds modules in
connected graphs. It is based on random walks and assumes that
the random walker is trapped in dense parts of a network [26].
For further network evaluation we used the Functional
Annotation Tool of the DAVID database [27]. The networks
were visualized with Cytoscape 2.8.3 [71] and Cytoscape Web
1.0.2 [72].
Supporting Information
Figure S1 Enrichment of proliferation-related micro-
RNAs. The barplot of enrichment scores (ESs) of observed
microRNA target genes (cyan) and randomly selected targets
(grey). The ES of randomly selected microRNA targets is
illustrated as mean6stdev. Per microRNA we computed 1,000
random ESs. P-values between observed and random ESs were
obtained by counting the number of random ESs exceeding the
observed one.
(PDF)
Figure S2 Distribution of Dunn coefficients and indi-
ces determined by FCM clustering. (A) Assessing the
optimal fuzziness parameter. The plot illustrates the Dunn
coefficients (y-axis) among a range of fuzziness parameters (x-
axis) for different cluster numbers. The fuzziness was set to 1.1,
where the Dunn coefficient distribution exceeds 0.5 for all cluster
numbers. (B) Determining the optimal cluster number. The plot
shows the Dunn indices (y-axis) among a range of cluster
numbers (x-axis) for different fuzziness parameters. The optimal
cluster number was set to 2, where the Dunn index reached its
maximum value.
(PDF)
Figure S3 Node degree distribution of the microRNA
and TF co-regulatory networks. The plots show the fraction
of proteins (y-axis) among all node degrees (x-axis) from the
microRNA and TF co-regulatory networks (grey) of (A) C1 and (B)
C2. Different colors indicate distinct degree distributions of
different node types. Horizontal lines mark the average node
degree of individual node types. The values of the average node
degrees are listed in the plots’ legends.
(PDF)
Figure S4 MicroRNA and TF co-regulatory network
modules derived from C1. The figure shows network modules
defined by the walktrap algorithm. The modules C1.1 to C2.6 are
labeled from (A) to (F). Node shapes correspond to the distinct
node types: microRNAs (diamond), TFs (triangle), primary target
(rectangle), and secondary target (ellipse). Yellow edges mark TF-
DNA interactions, blue edges microRNA-target interactions, and
dashed grey edges protein interactions. The red/green color code
indicates the log2 FC.
(PDF)
Figure S5 MicroRNA and TF co-regulatory network
modules derived from C2. The figure shows network modules
defined by the walktrap algorithm. The modules C2.1 to C2.6 are
labeled from (A) to (F). Node shapes correspond to the distinct
node types: microRNAs (diamond), TFs (triangle), primary target
(rectangle), and secondary target (ellipse). Yellow edges mark TF-
DNA interactions, blue edges microRNA-target interactions, and
dashed grey edges protein interactions. The red/green color code
indicates the log2 FC. The C2.1 module implicated in negative
regulation of differentiation of osteoblast cells is tagged with a red
frame.
(PDF)
Figure S6 miR-9-5p and SP1 target gene associations.
The network is derived from the STRING 9.0 database [42]. It
illustrates experimental and literature-mined functional associa-
tions between miR-9-5p and SP1 target genes.
(TIF)
Figure S7 Module C2.1 target gene associations. The
network is derived from the STRING 9.0 database [42]. It
illustrates experimental and literature-mined functional associa-
tions between genes within the C2.1 network module.
(TIF)
Table S1 Enrichment of proliferation-related micro-
RNA target genes. Results of the hypergeometric test to
examine significantly enriched microRNA target genes within the
list of DE genes. The table marks the total number of predicted
target genes, the number of DE target genes, and the
corresponding FDR.
(XLS)
Table S2 Significant microRNA and TF co-regulatory 3-
node motifs. The table summarizes the number of common
target genes of each non-random microRNA and TF co-
regulatory pair with corresponding statistics.
(XLS)
Table S3 Significant microRNA and TF co-regulatory 4-
node motifs. The table summarizes the number of interacting
target genes of each non-random microRNA and TF co-
regulatory pair with corresponding statistics.
(XLS)
Table S4 Individual microRNA and TF co-regulatory 3-
node and 4-node motifs of C1.
(XLS)
Table S5 Individual microRNA and TF co-regulatory 3-
node and 4-node motifs of C2.
(XLS)
Table S6 MicroRNA and TF co-regulatory network
hubs. The table holds the node degree and betweenness
parameters of hub genes within the co-regulatory network of C1
and C2 for each node type.
(XLS)
Table S7 Over-represented KEGG pathways.
(XLS)
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